Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Sen spent a decade with Biocon and held various key roles,
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
The investment will catalyse various components of the IndiaAI Mission
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The validations confirm the completion of the applications and commence the scientific review process
Subscribe To Our Newsletter & Stay Updated
